Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GIM-122 by Georgiamune for Solid Tumor: Likelihood of Approval
GIM-122 is under clinical development by Georgiamune and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
GIM-531 by Georgiamune for Metastatic Melanoma: Likelihood of Approval
GIM-531 is under clinical development by Georgiamune and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
GIM-531 by Georgiamune for Solid Tumor: Likelihood of Approval
GIM-531 is under clinical development by Georgiamune and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...